| Literature DB >> 33556374 |
Adam Mischler1, Victoria Karakis1, Jessica Mahinthakumar1, Celeste K Carberry2, Adriana San Miguel1, Julia E Rager2, Rebecca C Fry2, Balaji M Rao3.
Abstract
The trophectoderm layer of the blastocyst-stage embryo is the precursor for all trophoblast cells in the placenta. Human trophoblast stem (TS) cells have emerged as an attractive tool for studies on early trophoblast development. However, the use of TS cell models is constrained by the limited genetic diversity of existing TS cell lines and restrictions on using human fetal tissue or embryos needed to generate additional lines. Here we report the derivation of two distinct stem cell types of the trophectoderm lineage from human pluripotent stem cells. Analogous to villous cytotrophoblasts in vivo, the first is a CDX2- stem cell comparable with placenta-derived TS cells-they both exhibit identical expression of key markers, are maintained in culture and differentiate under similar conditions, and share high transcriptome similarity. The second is a CDX2+ stem cell with distinct cell culture requirements, and differences in gene expression and differentiation, relative to CDX2- stem cells. Derivation of TS cells from pluripotent stem cells will significantly enable construction of in vitro models for normal and pathological placental development.Entities:
Keywords: differentiation; embryonic stem cell; extravillous trophoblast; induced pluripotent stem cell; placenta; syncytiotrophoblast; trophoblast; trophoblast stem cells
Year: 2021 PMID: 33556374 PMCID: PMC7948510 DOI: 10.1016/j.jbc.2021.100386
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157